Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Biodefense Market 2017-2021 - Key Vendors are Altimmune, Bavarian Nordic, DynPort Vaccine Company (DVC) & Emergent BioSolutions - Research and Markets

Research and Markets
Posted on: 14 Dec 17

The "Global Biodefense Market 2017-2021" report has been added to Research and Markets' offering.

The global biodefense market to grow at a CAGR of 5.41% during the period 2017-2021.

Global Biodefense market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Biological agents used in warfare may prove to be more potent than conventional weapons. In the last century, the developments made in biochemistry and biotechnology have simplified the production of such weapons. Genetic engineering can be used to create new pathogens by manipulating genes, thereby giving rise to a whole new generation of genetically modified bioweapons. Factors such as ease of production, availability of technical know-how, and the extensive accessibility of biological agents have further led to the threat of biological weapons.

The latest trend gaining momentum in the market is Government initiatives. Biological agents are easy to obtain as these are naturally present in the environment. The possibility of developing novel weapons through the use of these agents is alarming. Laboratories, across the world, are working on the development of advanced detection systems to identify areas and populations at risk of bioterrorism, provide early warning, and facilitate prompt treatment. Forensic technologies in many countries such as the US are working on identifying biological agents, their environmental origins, and their initial sources. Efforts include sanitization technologies to reinstate facilities without causing any additional concerns.

Key vendors

  • Altimmune
  • Bavarian Nordic
  • DynPort Vaccine Company (DVC)
  • Emergent BioSolutions

Other prominent vendors

  • Acambis
  • Achaogen
  • Cleveland BioLabs
  • Elusys Therapeutics

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Five Forces Analysis

Part 07: Market Segmentation By Application

Part 08: Regional Landscape

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 14/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.